NL-OMON50851已完成4 期
The RTX-COVAC study: humoral response to COVID-19 vaccination after rituximab, and relation with dose and vaccination timing. A prospective cohort study. - RTX-COVAC
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 259
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Rheumatoid arthritis: either 2010 EULAR/ACR RA and/or 1987 ACR RA criteria
- •and/or clinical diagnosis of the treating rheumatologist;
- •* Treatment with at least one dose of rituximab (most of the times 200 mg, 500
- •mg or 1000 mg one or two times, but all dosages are included) in the year prior
- •to the COVID-19 vaccine;
- •* Expected to receive a registered COVID-19 vaccine or have received a
- •registered COVID-19 vaccine in the last 6 months;
- •* *16 years old and mentally competent;
- •* Ability to read and communicate in Dutch.
排除标准
- •* Not eligible (for example allergic to one of vaccine ingredients) or not
- •willing to receive the COVID-19 vaccine;
研究者
相似试验
进行中（未招募）
1 期
Research into the effect of the COVID-vaccine in patients who are treated with rituximab (RTX-COVAC study)MedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2021-000710-42-NLSint Maartenskliniek270
已完成
不适用
Investigating the immune response to COVID-19 vaccination in lung transplantation patients (COVALENT study)NL-OMON22289niversity Medical Center Groningen (UMCG)180
招募中
不适用
Immune response and therapy assessment to COVID-19 Vaccinations in people with Diabetes Mellitus – an observational pilot studyE10E11Type 2 diabetes mellitusType 1 diabetes mellitusDRKS00024879Division Exercise Physiology and Metabolism60
招募中
不适用
Study of immunologic response after COVID-19 vaccination in kidney transplant recipientsImmune response after COVID-19 vaccination in immunosuppressed patientsCovid-19vaccinekidney transplantimmunosuppressionTCTR20210611006Ratchadapiseksompotch Fund60
尚未招募
不适用
Humoral immune responses after receiving COVID-19 vaccination in cirrhotic patients.CirrhosisvaccinationCOVID-19cirrhosis, vaccination, COVID-19, CoronaVac, AstraZeneca, SARS-CoV-2 vaccine.TCTR20210622002Faculty of Medicine, Prince of Songla University100